PAG
NVAX icon

Private Advisor Group’s Novavax NVAX Stock Holding History

Private Advisor Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
47,893
+15,650
+49% +$140K ﹤0.01% 1864
2026
Q1 		$262K Sell
32,243
-14,426
-31% -$131K ﹤0.01% 2286
2025
Q4 		$314K Buy
46,669
+1,986
+4% +$15K ﹤0.01% 2130
2025
Q3 		$387K Buy
44,683
+17,889
+67% +$139K ﹤0.01% 1922
2025
Q2 		$169K Buy
26,794
+4,244
+19% +$28.1K ﹤0.01% 2265
2025
Q1 		$145K Buy
22,550
+558
+3% +$4.61K ﹤0.01% 2150
2024
Q4 		$177K Sell
21,992
-519
-2% -$5K ﹤0.01% 2111
2024
Q3 		$284K Buy
22,511
+36
+0.2% +$465 ﹤0.01% 1985
2024
Q2 		$285K Buy
22,475
+11,348
+102% +$114K ﹤0.01% 1924
2024
Q1 		$53.2K Sell
11,127
-1,330
-11% -$6.17K ﹤0.01% 2242
2023
Q4 		$59.8K Buy
12,457
+1,297
+12% +$7.94K ﹤0.01% 2155
2023
Q3 		$80.8K Buy
+11,160
New +$89.2K ﹤0.01% 1988
2023
Q1 		– Sell
-17,484
Closed -$180 – 2017
2022
Q4 		$180 Buy
17,484
+1,282
+8% +$22.6K ﹤0.01% 1526
2022
Q3 		$295K Sell
16,202
-1,191
-7% -$51.6K ﹤0.01% 1480
2022
Q2 		$895K Buy
17,393
+2,141
+14% +$111K 0.01% 1121
2022
Q1 		$1.12M Buy
15,252
+4,907
+47% +$438K 0.01% 1039
2021
Q4 		$1.48M Sell
10,345
-688
-6% -$118K 0.01% 939
2021
Q3 		$2.29M Buy
11,033
+1,921
+21% +$423K 0.01% 835
2021
Q2 		$1.94M Buy
9,112
+403
+5% +$73.8K 0.02% 774
2021
Q1 		$1.58M Sell
8,709
-194
-2% -$38.7K 0.02% 801
2020
Q4 		$993K Buy
8,903
+1,236
+16% +$131K 0.01% 907
2020
Q3 		$831K Buy
7,667
+3,447
+82% +$420K 0.01% 859
2020
Q2 		$352K Buy
+4,220
New +$161K ﹤0.01% 1150

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Private Advisor Group's NVAX Position: Q2 2026 in Review

Private Advisor Group increased its Novavax (NVAX) stake by 49% in Q2 2026, buying an estimated $140K and bringing the position to 47,893 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Private Advisor Group first reported a position in NVAX in Q2 2020 and has held it in 23 quarters since. The position peaked at $2.29M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Private Advisor Group held 47,893 shares of Novavax worth $451K as of Q2 2026.
  • Private Advisor Group bought 15,650 Novavax shares in Q2 2026, an estimated $140K.
  • Novavax made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1864 holding.
  • Private Advisor Group first reported a position in Novavax in Q2 2020 and has held it in 23 quarters since.
  • Private Advisor Group's Novavax position peaked at $2.29M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.